神经美容市场－全球产业规模、份额、趋势、机会和预测：按产品类型、最终用途、销售管道、地区和竞争格局划分，2021-2031年

全球神经美容市场预计将从 2025 年的 21.1 亿美元成长到 2031 年的 33.9 亿美元，复合年增长率为 8.22%。

神经美容产品是指富含生物活性成分的局部用製剂，这些成分能够与皮肤神经末梢相互作用，从而透过脑-皮肤轴影响情绪和皮肤健康。该市场的成长主要得益于消费者对整体个人护理解决方案日益增长的兴趣，这些方案认识到心理健康与皮肤状况之间错综复杂的关係。此外，人们对心理皮肤病学的理解不断加深，以及对能够主动缓解压力相关问题的美容方法的广泛需求，也推动了这一领域的发展。

阻碍整体市场成长的主要障碍之一是，科学证实情绪改善功效的说法十分复杂，这往往会导致监管机构的严格审查。根据全球健康研究所的数据，自2019年以来，心理健康领域的复合年增长率达到12.4%，凸显了该领域在2024年的巨大经济潜力。儘管市场环境有利，但神经美容产品製造商仍面临着向监管机构证明其生理功效的巨大挑战，以便充分把握蓬勃发展的心理健康市场带来的机会。

市场驱动因素

随着消费者对「脑-肤」连结的认知不断加深，人们越来越将情绪健康与皮肤状况连结起来，市场正经历一场根本性的重组。这种转变推动了对心理皮肤病学产品的需求，这些产品能够透过整体护理方案改善压力引起的症状，例如痤疮和湿疹。为了因应这一趋势，各大品牌正在开发强调「身心」关係的计画和合作关係，并将焦点从表面治疗转向情绪自我护理。 Ovid 2025 年的研究报告《患者对皮肤健康的认知：压力与饮食》印证了这种趋势，该报告显示，66% 的受访者确认压力会直接影响他们的皮肤健康，这表明消费者对能够解决这些心理影响的产品有着强烈的需求。

同时，包括神经肽和适应原在内的生物活性成分配方技术的进步，正引领调节皮肤反应产品的主流趋势。製造商正有效地将神经科学与化妆品结合，利用能够与皮肤神经末梢相互作用的成分，显着提升情绪并达到抗衰老龄化的效果。这项技术进步对于产业扩张至关重要，尤其是在抗衰老领域。 Sepic发布的《2024年塑造护肤未来的四大趋势》（2024年12月）报告预测，从2023年到2032年，该产业将以6.7%的年均成长率成长。此外，当前的经济环境依然有利。根据 2025 年 8 月欧洲水疗杂誌的一篇文章，该文章引用了英国美容协会 2025 年的报导，美容行业将在 2024 年直接为英国GDP 贡献 304 亿英镑（约 5.4 兆日圆），这表明此类创新投资的环境有利。

市场挑战

全球神经化妆品市场面临的主要障碍在于，如何科学地证明其具有调节情绪的功效是一项复杂的挑战，这也导致了严格的监管审查。传统护肤品通常使用标准指标来衡量诸如减少皱纹和保湿效果等生理指标，而神经化妆品则依赖主观的心理效应。因此，声称能够改变精神状态或生理功能的产品往往被监管机构归类为药品而非化妆品。这种分类造成了复杂且成本高昂的合规环境，实际上为缺乏资源进行药品级临床试验的创新品牌设定了很高的进入门槛。

这些严格的证明要求迫使企业淡化其行销宣传，最终削弱了产品独特的「脑肤护肤」价值提案，从而限制了市场成长。由于品牌无法合法地宣传特定的神经活化效果，因此无法吸引那些原本非常愿意在个人照护上消费的消费者。例如，根据欧洲化妆品协会（Cosmetics Europe）预测，2024年，欧洲个人护理和化妆品市场的零售额将达到1,040亿欧元。儘管存在如此巨大的经济机会，但神经化妆品领域却难以有效利用这笔资金，因为法规结构限制了製造商做出在竞争激烈的市场中脱颖而出所需的精准而有力的宣传。

市场趋势

随着功能性香精和神经香精技术的进步，嗅觉产品正在发生重大转变，其设计目的不再只是消除异味，而是调节情绪。这一趋势利用嗅球和边缘系统之间的直接联繫，提供特定的情绪改善效果，例如提高注意力、缓解压力。根据《亚洲化妆品设计》2025年1月刊的《2025年香氛趋势》报导，dsm-firmenich的数据显示，亚太地区75%的女性消费者使用香水来改善情绪，这印证了市场对这类产品的需求。因此，製造商正在产品中加入基于神经科学的成分，以激活特定的神经通路，从而将香水定位为日常情绪调节的重要工具。

同时，受「皮肤化」趋势的推动——该趋势将头皮视为一种感官——神经活化成分正迅速扩展到头髮和头皮护理领域。各大品牌正在研发针对皮肤神经末梢的免冲洗护髮产品，以舒缓压力引起的过敏和炎症，从而将护髮提升为一种疗癒仪式。随着消费者越来越重视头皮健康对整体健康的重要性，这一品类正迅速获得商业性认可。根据《化妆品商业》（Cosmetics Business）2025年10月刊发布的「头皮和头髮护理领域六大配方创新」报告，2024年上半年欧洲免洗护髮产品的销售额增长了51%。这报导了结合皮肤病学和感官健康概念的产品的巨大潜力，这些产品旨在解决头髮与大脑之间的联繫。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球神经美容市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 产品类型（护肤、护髮品、沐浴淋浴设备、彩妆品、香水/香氛、其他）
  • 依最终用途（女性、男性）
  • 销售管道（超级市场/大卖场、线上通路、便利商店、专卖店、其他通路）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美神经美容市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲神经美容市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区神经美容市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲神经美容市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲神经美容市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球神经美容市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• LUKSO Neurocosmetics
• Swanrose Inc.
• INSKIN COSMEDICS Group Pty Ltd
• The Algenist LLC
• Arkana Cosmetics Sp. z oo Sp. K.
• Benetton Group Srl
• L'Oreal SA
• The Estee Lauder Companies Inc.
• SkinSoul Cosmetics
• Amyris, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Neurocosmetics Market is projected to expand from USD 2.11 Billion in 2025 to USD 3.39 Billion by 2031, registering a CAGR of 8.22%. Neurocosmetics are defined as topical formulations enriched with bioactive ingredients that engage with cutaneous nerve endings to influence both mood and skin health through the brain-skin axis. This market trajectory is primarily driven by escalating consumer interest in holistic personal care solutions that acknowledge the intricate relationship between mental well-being and dermatological issues. Furthermore, the sector is bolstered by a growing understanding of psychodermatology and a widespread desire for beauty regimens that actively mitigate stress-related concerns.

One significant obstacle hindering broader market growth is the complexity involved in scientifically validating mood-enhancement claims, a factor that frequently invites rigorous regulatory examination. Data from the Global Wellness Institute indicates that the mental wellness sector has expanded by an average annual rate of 12.4% since 2019, highlighting the robust economic potential for this category in 2024. Despite this favorable environment, neurocosmetics manufacturers continue to face the substantial challenge of demonstrating physiological efficacy to regulators in order to fully capitalize on the thriving mental wellness landscape.

Market Driver

The market is being fundamentally reshaped by heightened consumer awareness regarding the connection between the brain and skin, as individuals increasingly link their emotional well-being to their dermatological appearance. This shift is driving demand for psychodermatological products capable of treating stress-induced conditions, such as acne and eczema, through holistic care routines. In response, brands are rolling out initiatives and partnerships that highlight the "mind-skin" relationship, transitioning focus from superficial treatments to emotional self-care. This readiness is evidenced by a 2025 study titled "Patient Perception of Skin Health: Stress and Diet" reported by Ovid, where 66% of participants confirmed that stress directly affects their skin health, signaling strong consumer appetite for products addressing these psychological effects.

Concurrently, advancements in research are facilitating the mainstream adoption of bioactive formulations containing neuropeptides and adaptogens intended to modulate skin responses. Manufacturers are leveraging ingredients that interact with cutaneous nerve endings to offer distinct mood-enhancing and anti-aging benefits, effectively merging the fields of neuroscience and cosmetics. This technical progression is vital for sector expansion, especially within the anti-aging domain, which Seppic's "4 trends shaping the future of skincare in 2024" report (December 2024) estimates will grow at an annual average rate of 6.7% from 2023 to 2032. Additionally, the economic backdrop remains supportive; as per an August 2025 article in European Spa Magazine citing the British Beauty Council's 2025 report, the beauty industry contributed £30.4 billion directly to the UK's GDP in 2024, indicating a strong environment for these innovative investments.

Market Challenge

The central obstacle impeding the Global Neurocosmetics Market is the intricate challenge of scientifically proving claims regarding mood modulation, which subsequently attracts intense regulatory scrutiny. In contrast to traditional skincare where physical results like wrinkle reduction or hydration are measurable via standard metrics, neurocosmetics depend on subjective psychological effects. Consequently, regulatory authorities often classify products claiming to modify mental states or physiological functions as drugs rather than cosmetics. This classification creates a complex and costly compliance landscape that effectively serves as a high barrier to entry for innovative brands lacking the resources to conduct pharmaceutical-grade clinical trials.

This stringent need for validation restricts market growth by forcing companies to soften their marketing claims, thereby stripping products of their distinct "brain-skin" value proposition. Because brands cannot legally communicate specific neuro-active benefits, they are unable to fully engage a consumer base that is otherwise eager to spend on personal care. For example, Cosmetics Europe reported that the European personal care and cosmetics market achieved retail sales of €104 billion in 2024. Despite this massive economic opportunity, the neurocosmetics segment struggles to effectively access this capital because regulatory frameworks prevent manufacturers from making the precise, potent claims required to stand out in a competitive market.

Market Trends

A pivotal shift is occurring with the rise of functional fragrance and neuro-scent technologies, where olfactory products are designed to modulate emotional states rather than simply mask odors. This trend utilizes the direct link between the olfactory bulb and the limbic system to provide concrete mood-enhancing effects, such as improved focus and stress reduction. According to a January 2025 article in CosmeticsDesign-Asia titled "Fragrance trends 2025," data from dsm-firmenich indicates that 75% of female consumers in the Asia-Pacific region use fragrance specifically to improve their mood, validating the demand for these solutions. Consequently, manufacturers are incorporating neuroscience-backed ingredients that activate specific neural pathways, positioning fragrance as an essential tool for daily emotional regulation.

At the same time, the market is seeing neuro-active ingredients expand into hair and scalp care, a movement driven by the "skinification" of the scalp as a sensory organ. Brands are developing leave-in treatments that target cutaneous nerve endings to soothe stress-induced sensitivity and inflammation, effectively turning hair care into a therapeutic ritual. This category is gaining rapid commercial traction as consumers increasingly view scalp health as vital to their overall wellness. As reported by Cosmetics Business in the "Top 6 formulation-forward trends in scalp and hair care" article from October 2025, sales of leave-in scalp treatments in Europe rose by 51% in the first half of 2024, highlighting the potential of products that blend dermatological science with sensory well-being to address the hair-brain connection.

Key Market Players

• LUKSO Neurocosmetics
• Swanrose Inc.
• INSKIN COSMEDICS Group Pty Ltd
• The Algenist LLC
• Arkana Cosmetics Sp. z o.o. Sp. K.
• Benetton Group S.r.l.
• L'Oreal S.A.
• The Estee Lauder Companies Inc.
• SkinSoul Cosmetics
• Amyris, Inc.

Report Scope

In this report, the Global Neurocosmetics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Neurocosmetics Market, By Product Type

• Skin Care
• Hair Care
• Bath and Shower
• Color Cosmetics
• Perfumes/Fragrances
• Others

Neurocosmetics Market, By End Use

• Women
• Men

Neurocosmetics Market, By Sales Channel

• Supermarket/Hypermarket
• Online
• Convenience Stores
• Specialty Stores
• Others

Neurocosmetics Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Neurocosmetics Market.

Available Customizations:

Global Neurocosmetics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Neurocosmetics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Skin Care, Hair Care, Bath and Shower, Color Cosmetics, Perfumes/Fragrances, Others)
  • 5.2.2. By End Use (Women, Men)
  • 5.2.3. By Sales Channel (Supermarket/Hypermarket, Online, Convenience Stores, Specialty Stores, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Neurocosmetics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By End Use
  • 6.2.3. By Sales Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Neurocosmetics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By End Use
      • 6.3.1.2.3. By Sales Channel
  • 6.3.2. Canada Neurocosmetics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By End Use
      • 6.3.2.2.3. By Sales Channel
  • 6.3.3. Mexico Neurocosmetics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By End Use
      • 6.3.3.2.3. By Sales Channel

7. Europe Neurocosmetics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By End Use
  • 7.2.3. By Sales Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Neurocosmetics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By End Use
      • 7.3.1.2.3. By Sales Channel
  • 7.3.2. France Neurocosmetics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By End Use
      • 7.3.2.2.3. By Sales Channel
  • 7.3.3. United Kingdom Neurocosmetics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By End Use
      • 7.3.3.2.3. By Sales Channel
  • 7.3.4. Italy Neurocosmetics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By End Use
      • 7.3.4.2.3. By Sales Channel
  • 7.3.5. Spain Neurocosmetics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By End Use
      • 7.3.5.2.3. By Sales Channel

8. Asia Pacific Neurocosmetics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By End Use
  • 8.2.3. By Sales Channel
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Neurocosmetics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By End Use
      • 8.3.1.2.3. By Sales Channel
  • 8.3.2. India Neurocosmetics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By End Use
      • 8.3.2.2.3. By Sales Channel
  • 8.3.3. Japan Neurocosmetics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By End Use
      • 8.3.3.2.3. By Sales Channel
  • 8.3.4. South Korea Neurocosmetics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By End Use
      • 8.3.4.2.3. By Sales Channel
  • 8.3.5. Australia Neurocosmetics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By End Use
      • 8.3.5.2.3. By Sales Channel

9. Middle East & Africa Neurocosmetics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By End Use
  • 9.2.3. By Sales Channel
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Neurocosmetics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By End Use
      • 9.3.1.2.3. By Sales Channel
  • 9.3.2. UAE Neurocosmetics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By End Use
      • 9.3.2.2.3. By Sales Channel
  • 9.3.3. South Africa Neurocosmetics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By End Use
      • 9.3.3.2.3. By Sales Channel

10. South America Neurocosmetics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By End Use
  • 10.2.3. By Sales Channel
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Neurocosmetics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By End Use
      • 10.3.1.2.3. By Sales Channel
  • 10.3.2. Colombia Neurocosmetics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By End Use
      • 10.3.2.2.3. By Sales Channel
  • 10.3.3. Argentina Neurocosmetics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By End Use
      • 10.3.3.2.3. By Sales Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Neurocosmetics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. LUKSO Neurocosmetics
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Swanrose Inc.
• 15.3. INSKIN COSMEDICS Group Pty Ltd
• 15.4. The Algenist LLC
• 15.5. Arkana Cosmetics Sp. z o.o. Sp. K.
• 15.6. Benetton Group S.r.l.
• 15.7. L'Oreal S.A.
• 15.8. The Estee Lauder Companies Inc.
• 15.9. SkinSoul Cosmetics
• 15.10. Amyris, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer